TY  - GEN
AU  - Hall,Amy B
AU  - Newsome,Dave
AU  - Wang,Yuxin
AU  - Boucher,Diane M
AU  - Eustace,Brenda
AU  - Gu,Yong
AU  - Hare,Brian
AU  - Johnson,Mac A
AU  - Milton,Sean
AU  - Murphy,Cheryl E
AU  - Takemoto,Darin
AU  - Tolman,Crystal
AU  - Wood,Mark
AU  - Charlton,Peter
AU  - Charrier,Jean-Damien
AU  - Furey,Brinley
AU  - Golec,Julian
AU  - Reaper,Philip M
AU  - Pollard,John R
TI  - Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970
SN  - 1949-2553
PY  - 2015///0605
KW  - Animals
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - pharmacology
KW  - Ataxia Telangiectasia Mutated Proteins
KW  - antagonists & inhibitors
KW  - Cell Line, Tumor
KW  - Cisplatin
KW  - administration & dosage
KW  - DNA
KW  - drug effects
KW  - DNA Damage
KW  - Drug Synergism
KW  - Female
KW  - Humans
KW  - Isoxazoles
KW  - Mice
KW  - Mice, SCID
KW  - Phosphorylation
KW  - Protein Kinase Inhibitors
KW  - Pyrazines
KW  - Random Allocation
KW  - Signal Transduction
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.18632/oncotarget.2158
ER  -